United Health Products (UEEC) Return on Capital Employed (2011 - 2026)

United Health Products (UEEC) has 16 years of Return on Capital Employed data on file, last reported at 26.4% in Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 26.4%, down 16333.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 26.4% (down 16333.0% YoY), and the FY2025 annual result was 61.8%, down 8540.0% from the prior year.
• Return on Capital Employed declined to 26.4% in Q1 2026 per UEEC's latest filing, from 60.34% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 241.43% in Q3 2022 and troughed at 26.4% in Q1 2026.
• A 5-year average of 136.64% and a median of 145.67% in 2023 frame the typical range for Return on Capital Employed.
• The sharpest annual moves came in 2022 and 2025: Return on Capital Employed slumped 8424466 bps in 2022, then jumped 8582 bps in 2025.
• A 5-year view of Return on Capital Employed shows it stood at 139.11% in 2022, then climbed by 6 bps to 147.94% in 2023, then slipped by 5 bps to 140.31% in 2024, then sank by 57 bps to 60.34% in 2025, then sank by 56 bps to 26.4% in 2026.
• Business Quant data shows UEEC's Return on Capital Employed at 26.4% in Q1 2026, 60.34% in Q4 2025, and 144.71% in Q3 2025.